{
    "table_id": "finqa_ac2bdf22fe",
    "source": "finqa",
    "original_metadata": {
        "source_dataset": "finqa",
        "document_id": "ABMD/2009/page_85.pdf-1",
        "pre_text_caption_evidence": [
            "abiomed , inc .",
            "and subsidiaries notes to consolidated financial statements 2014 ( continued ) note 12 .",
            "stock award plans and stock based compensation ( continued ) compensation expense recognized related to the company 2019s espp was approximately $ 0.1 million for each of the years ended march 31 , 2009 , 2008 and 2007 respectively .",
            "the fair value of shares issued under the employee stock purchase plan was estimated on the commencement date of each offering period using the black-scholes option-pricing model with the following assumptions: ."
        ],
        "question": "what was the range of volatility ( % (  % ) ) in the black scholes calculation for the three year period?\\\\n"
    },
    "dimensions": {
        "rows": 3,
        "columns": 4
    },
    "schema": {
        "columns": [
            "",
            "2009",
            "2008",
            "2007"
        ],
        "dtypes": {
            "": "object",
            "2009": "object",
            "2008": "object",
            "2007": "object"
        }
    }
}